Poppers-associated retinal toxicity.

Poppers-associated retinal toxicity.
Catherine Vignal-Clermont, Isabelle Audo, José-Alain Sahel, Michel Paques
To cite this version:
Catherine Vignal-Clermont, Isabelle Audo, José-Alain Sahel, Michel Paques. Poppersassociated retinal toxicity.. The New England Journal of Medicine, 2010, 363 (16), pp.1583-5.
<10.1056/NEJMc1005118>. <inserm-00528153>
HAL Id: inserm-00528153
http://www.hal.inserm.fr/inserm-00528153
Submitted on 21 Oct 2010
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
correspondence
blood pressure is not reproducible enough to
have clinical value. Optimal diets improve microvascular dysfunction, and they reduce blood
pressure during the day and at night.2 Thus, diet
is the treatment of choice for these linked disorders, and low sodium intake would have special
effectiveness in such patients. We cannot agree
with the opinion of de Oliveira and Santana to
prescribe combination antihypertensive drug
treatment for the primary prevention of cardiovascular disease in a patient with newly discovered essential hypertension. Such a patient could
avoid drug treatment entirely if she optimizes her
diet. Drug treatment for hypertension, although
unquestionably effective in reducing cardiovascular events, has adverse effects that partially offset its benefits, as shown in a recent large trial.3
We agree with the statement by Oh and colleagues concerning sugars, and in our article we
stated that “we encourage patients to eat . . . vegetables and fruit instead of snacks and desserts high in sugars, [and] fruit itself rather than
juice.” We also recommended that “sections of
the market that contain sweetened beverages,
candies, and cookies should be avoided entirely”
when shopping for food. We also agree that controlled trials are needed to determine direct effects that sugar and other carbohydrates have on
blood pressure. We are completing such a trial using the controlled feeding methods of the DASH
study (Effect of Amount and Type of Dietary Carbohydrates on Risk for Cardiovascular Heart Disease and Diabetes [OmniCarb]; ClinicalTrials.gov
number, NCT00608049).
Frank M. Sacks, M.D.
Hannia Campos, Ph.D.
Harvard School of Public Health
Boston, MA
[email protected]
Since publication of their article, the authors report no further potential conflict of interest.
1. Reducing salt intake in populations: report of a WHO forum
and technical meeting, 5-7 October 2006, Paris, France. Geneva:
World Health Organization, 2007.
2. Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens 2006;24:1627-32.
3. The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;
362:1575-85.
Poppers-Associated Retinal Toxicity
To the Editor: “Poppers” (slang for various
forms of alkyl nitrite) are volatile nitric oxide
donors that have been used for decades as recreational drugs. Both the popularity of and legal
tolerance for poppers have led to the perception
that these drugs are relatively innocuous.1 Here,
we describe four patients who were seen within a
few months of one another and who had prolonged visual loss as a result of damage to foveal
photoreceptors shortly after inhaling poppers.
In January 2010, Patient 1, a 27-year-old
woman, presented with an 11-day history of a
reduction in bilateral vision and a “central bright
dot” in both eyes. The night before the onset of
symptoms, she had attended a party, at which
both she and Patient 2 had inhaled poppers
(brand name, Jungle Juice) and consumed approximately half a bottle of high-grade alcohol.
Patient 1 was an occasional consumer of other
brands of poppers but reported having had no
previous visual symptoms. Her medical history
was unremarkable.
The visual acuity was 20/50 in the right eye
and 20/40 in the left eye. Anterior segments and
intraocular pressure were normal. The fundus
examination showed a yellow foveal dot in both
eyes (Fig. 1A and 1B, top row). Findings on highresolution optical coherence tomography were
consistent with damage to the photoreceptor
outer segment in the fovea of both eyes (Fig. 1A
and 1B, bottom row). Color vision and full-field
electroretinograms were normal. Isopropyl nitrite
was identified by gas chromatography–mass
spectrometry in the vapors from the popper vial.
On follow-up examination 1 month later, the visual symptoms and ophthalmologic examination
were unchanged.
Within a 3-month period, we examined three
other patients who also had visual loss with
central phosphenes after inhaling isopropyl nitrite (see the Supplementary Appendix, available
with the full text of this letter at NEJM.org). Two
of these patients showed resolution of symptoms over several weeks.
To our knowledge, over the past 10 years,
there have been only two case reports of visual
n engl j med 363;16 nejm.org october 14, 2010
The New England Journal of Medicine
Downloaded from www.nejm.org on October 21, 2010. For personal use only. No other uses without permission.
Copyright © 2010 Massachusetts Medical Society. All rights reserved.
1583
The
n e w e ng l a n d j o u r na l
A
of
m e dic i n e
B
Figure 1. Retinal Images of Patient 1 at Presentation 11 Days after Inhalation of Poppers.
Shown are images of the patient’s right eye, with visual acuity of 20/50 (Panel A), and left eye, with visual acuity of
20/40 (Panel B). In the top row, fundus photographs show a bilateral yellow foveal dot (arrows). In the bottom row, optical coherence tomography shows altered reflectance of photoreceptor outer segments in the foveae (arrowheads).
loss after inhalation of poppers,2,3 and the anatomical basis of this injury remains elusive. Thus,
vision loss after intake of poppers is considered
to be a rare event, although poppers-induced
phosphenes are reported in Internet forums. The
reason for the apparent outbreak of popper toxicity that we report here remains to be determined. It may have been due to an increased use
of poppers in the population, to the availability
of more powerful popper brands, or to improvements in retinal imaging technologies.
Because the only compound we detected in
the vapors from the vials was isopropyl nitrite, a
very potent nitric oxide donor, it is likely that the
visual symptoms were due to acute, massive release of nitric oxide. Nitric oxide modulates
photoreceptor metabolism and function. It also
activates guanylate cyclase,4 a key enzyme for
recovery of photoreceptor function after phototransduction. However, guanylate cyclase activation is predicted to decrease light sensitivity,
whereas the phosphenes reported by our patients suggest increased light sensitivity. Retinal
damage was functionally and anatomically limited to the foveal center, a situation similar to
that observed in photic injury. Experimentally,
nitric oxide is indeed known to contribute to photic injury.5 However, our patients reported that
they had not stared at bright lights. Because nitric oxide is a potent vasodilator, acute changes in
ocular perfusion pressure might have contribut-
1584
n engl j med 363;16
ed to retinal damage, although photoreceptors
are relatively resistant to short-term circulatory
changes.
Consumers and ophthalmologists should be
aware of the possible retinal toxicity of poppers.
In patients with recent bilateral visual loss and
phosphenes, this diagnosis should be considered. Finally, the determination of the molecular
basis for the toxic effects of poppers may be of
interest to further document the role of nitric
oxide in retinal function and diseases and to
identify potential approaches to counter such
toxicity.
Catherine Vignal-Clermont, M.D.
Fondation Ophtalmologique Adolphe de Rothschild
Paris, France
Isabelle Audo, M.D., Ph.D.
José-Alain Sahel, M.D.
Michel Paques, M.D., Ph.D.
Quinze-Vingts Hospital
Paris, France
[email protected]
Supported by the Institut National de la Santé et de la Recherche Médicale, the Direction de l’Hospitalisation et des Soins, and
the Foundation Fighting Blindness.
Disclosure forms provided by the authors are available with
the full text of this letter at NEJM.org.
1. Romanelli F, Smith KM, Thornton AC, Pomeroy C. Poppers:
epidemiology and clinical management of inhaled nitrite abuse.
Pharmacotherapy 2004;24:69-78.
2. Fledelius HC. Irreversible blindness after amyl nitrite inhalation. Acta Ophthalmol Scand 1999;77:719-21.
3. Pece A, Patelli F, Milani P, Pierro L. Transient visual loss
nejm.org
october 14, 2010
The New England Journal of Medicine
Downloaded from www.nejm.org on October 21, 2010. For personal use only. No other uses without permission.
Copyright © 2010 Massachusetts Medical Society. All rights reserved.
notices
after amyl isobutyl nitrite abuse. Semin Ophthalmol 2004;19:
105-6.
4. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its
role in retinal function and disease. Vision Res 1996;36:2979-94.
5. Goureau O, Jeanny JC, Becquet F, Hartmann MP, Courtois Y.
Protection against light-induced retinal degeneration by an inhibitor of NO synthase. Neuroreport 1993;13:233-6.
Correspondence Copyright © 2010 Massachusetts Medical Society.
instructions for letters to the editor
Letters to the Editor are considered for publication, subject
to editing and abridgment, provided they do not contain
material that has been submitted or published elsewhere.
Please note the following:
• Letters in reference to a Journal article must not exceed 175
words (excluding references) and must be received within
3 weeks after publication of the article.
• Letters not related to a Journal article must not exceed 400
words.
• A letter can have no more than five references and one figure
or table.
• A letter can be signed by no more than three authors.
• Financial associations or other possible conflicts of interest
must be disclosed. Disclosures will be published with the
letters. (For authors of Journal articles who are responding
to letters, we will only publish new relevant relationships
that have developed since publication of the article.)
• Include your full mailing address, telephone number, fax
number, and e-mail address with your letter.
• All letters must be submitted at authors.NEJM.org.
Letters that do not adhere to these instructions will not be
considered. We will notify you when we have made a decision
about possible publication. Letters regarding a recent Journal
article may be shared with the authors of that article. We are
unable to provide prepublication proofs. Submission of a
letter constitutes permission for the Massachusetts Medical
Society, its licensees, and its assignees to use it in the Journal’s
various print and electronic publications and in collections,
revisions, and any other form or medium.
corrections
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary
Syndromes (September 2, 2010;363:930-42). In Figure 1B (page
935), the y axis of the inset graph should have read, “0.00, 0.01,
0.02, 0.03, 0.04, 0.05,” rather than “0.0, 0.1, 0.2, 0.3, 0.4, 0.5.” We
regret the error. The article has been corrected at NEJM.org.
Case 14-2010: A 54-Year-Old Woman with Dizziness and Falls
(May 13, 2010;362:1815-23). In the last sentence of the Cerebral
Perfusion and Orthostatic Intolerance subsection of Differential
Diagnosis (page 1820), the parenthetical information should
have read, “(miosis and anhidrosis),” rather than “(meiosis and
anhidrosis).” The article has been corrected at NEJM.org.
Clostridium difficile — More Difficult Than Ever (October 30,
2008;359:1932-40). In reference 25 (page 1939), the second author’s name should have been listed as “Gerson M,” rather than
“Gerdsom M.” The article has been corrected at NEJM.org.
notices
Notices submitted for publication should contain a mailing
address and telephone number of a contact person or department. We regret that we are unable to publish all notices re-
ceived. Notices also appear on the Journal’s Web site (NEJM
.org/medical-conference). The listings can be viewed in their
entirety or filtered by specialty, location, or month.
Erasme University Hospital
The following meetings will be held in Brussels, unless otherwise indicated: “Doppler-Echocardiography in Intensive Care
Medicine” (Nov. 16–18); “16th Postgraduate Refresher Course:
Cardiovascular and Respiratory Physiology Applied to Intensive Care Medicine” (Nov. 30–Dec. 2); “Respiratory Monitoring” (Rome, Dec. 5–8); and “31st International Symposium on
Intensive Care and Emergency Medicine” (March 22–25).
Contact Erasme University Hospital, Université Libre de
Bruxelles, Intensive Care Department, Route de Lennik 808,
1070 Brussels, Belgium; or call (32) 2 555 3631; or fax (32)
2 555 4555; or e-mail [email protected]; or see http://www
.intensive.org.
American Society of Tropical Medicine
and Hygiene
The following meetings will be held in Atlanta: “Certificate
of Knowledge Examination” (Nov. 2) and “ASTMH 59th Annual Meeting” Nov. (3–7).
Contact the American Society of Tropical Medicine and Hygiene, 111 Deer Lake Rd., Suite 100, Deerfield, IL 60015; or call
(847) 480-9592; or fax (847) 480-9282; or e-mail info@astmh
.org; or see http://www.astmh.org.
International Scientific Conference
on Gastro-Intestinal Microbial Ecology
The conference will be held in Kosice, Slovakia, Nov. 9–11.
Contact the Organizing Secretariat, PAMIDA International
Ltd., Komenského 2656, 024 01 Kysucké Nové Mesto, Slovak
Republic; or call (421) 918 707371; or fax (421) 41 4000123;
or e-mail [email protected]; or see http://www
.gutmicroecology.net.
Abdominal Radiology Course 2011
The Annual Meeting and Postgraduate Course will be held
in Carlsbad, CA, March 20–25. It is jointly presented by the
Society of Gastrointestinal Radiologists and the Society of
Uroradiology.
Contact International Meeting Managers, 4550 Post Oak
Place, Suite 342, Houston, TX 77027; or call (713) 965-0566; or
fax (713) 960-0488; or see http://www.sgr.org or http://www
.uroradiology.org.
Harvard Medical School Center for Palliative
Care
The following course will be offered in Cambridge, MA:
“Program in Palliative Care Education and Practice” (April
5–12, Nov. 2–8, 2011; deadline for submission of applications,
Feb. 11).
Contact HMS Center for Palliative Care, Dana–Farber Cancer Institute, 44 Binney St., SW530B, Boston, MA 02115; or call
(617) 582-7859; or e-mail [email protected]; or see http://
www.hms.harvard.edu/pallcare/pcep.htm.
Dallas-Leipzig International Valve 2010
The conference will be held in Dallas, Dec. 9–11.
Contact Dallas-Leipzig International Valve, 7777 Forest
Lane, Suite C-742, Dallas, TX 75230; or e-mail info@
dallasleipzigvalve.org; or see http://www.dallasleipzigvalve.org.
Urgent Care Association of America
The following meeting will be held: “2010 Urgent Care Fall
Conference” (Phoenix, AZ, Oct. 22 and 23).
Contact Lou Ellen Horwitz, Urgent Care Association of
America, 4320 Winfield Rd., Suite 200, Warrenville, IL 60555;
or call (877) 698-2262; or fax (630) 836-8518; or e-mail
­[email protected].
n engl j med 363;16 nejm.org october 14, 2010
The New England Journal of Medicine
Downloaded from www.nejm.org on October 21, 2010. For personal use only. No other uses without permission.
Copyright © 2010 Massachusetts Medical Society. All rights reserved.
1585